Intelligence Driven Advisers’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
PCA
MSV
BTCPP
VFA
CAM
EB
AIM
FFA
QPBE
Intelligence Driven Advisers's LLY Position: Q3 2026 in Review
Intelligence Driven Advisers increased its Eli Lilly (LLY) stake by 9.7% in Q3 2026, buying an estimated $75.5K and bringing the position to 725 shares worth $839K. The position accounts for 0.14% of the portfolio, ranked #57.
Intelligence Driven Advisers first reported a position in LLY in Q2 2022 and has held it in 18 quarters since. The position peaked at $1.59M in Q3 2024. 255 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Intelligence Driven Advisers held 725 shares of Eli Lilly worth $839K as of Q3 2026.
- Intelligence Driven Advisers bought 64 Eli Lilly shares in Q3 2026, an estimated $75.5K.
- Eli Lilly made up 0.14% of Intelligence Driven Advisers's portfolio in Q3 2026, its #57 holding.
- Intelligence Driven Advisers first reported a position in Eli Lilly in Q2 2022 and has held it in 18 quarters since.
- Intelligence Driven Advisers's Eli Lilly position peaked at $1.59M in Q3 2024.
- 255 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Intelligence Driven Advisers's 13F filing for Q3 2026, filed 9 Oct 2026.